Literature DB >> 34464292

Is heart failure an obstacle to air travel?

Güliz Erdem1.   

Abstract

Rapid increasing trend in air travel brings necessity of urgent approach to health situations such as heart failure (HF). The prevalence of HF was projected to be more than 8 million patients ≥18 years of age in 2030; Main factors that contribute to physiological changes to cardiovascular system during a flight are changes in cabin pressure, humidity, stress, prolonged mobility. Identifying patients at risk of pre/post and during air travel along with adequate care by physicians and crew would help in better outcomes and comfortable travel for patients with HF.

Entities:  

Mesh:

Year:  2021        PMID: 34464292      PMCID: PMC8412051          DOI: 10.5152/AnatolJCardiol.2021.S105

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.475


  14 in total

1.  Operation Everest III (Comex '97): modifications of cardiac function secondary to altitude-induced hypoxia. An echocardiographic and Doppler study.

Authors:  A Boussuges; F Molenat; H Burnet; E Cauchy; B Gardette; J M Sainty; Y Jammes; J P Richalet
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

Review 2.  Air medical transport of cardiac patients.

Authors:  Vidal Essebag; Abdul R Halabi; Michael Churchill-Smith; Sohrab Lutchmedial
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

3.  Medical Guidelines for Airline Travel, 2nd ed.

Authors: 
Journal:  Aviat Space Environ Med       Date:  2003-05

Review 4.  Fitness to fly for passengers with cardiovascular disease.

Authors:  David Smith; William Toff; Michael Joy; Nigel Dowdall; Raymond Johnston; Liz Clark; Simon Gibbs; Nick Boon; David Hackett; Chris Aps; Mark Anderson; John Cleland
Journal:  Heart       Date:  2010-08       Impact factor: 5.994

5.  Cardiovascular disease and airline travel.

Authors:  Michael Joy
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

6.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

7.  Effects of reducing inspired oxygen concentration for one hour in patients with chronic heart failure: implications for air travel.

Authors:  James P Hobkirk; Thibaud Damy; Mandy Walters; Anna Bennett; Sarah J Smith; Lee Ingle; Andrew L Clark; John G F Cleland
Journal:  Eur J Heart Fail       Date:  2013-01-15       Impact factor: 15.534

8.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

Authors:  J A Heit; M D Silverstein; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  2000-03-27

9.  Experiences of air travel in patients with chronic heart failure.

Authors:  Lee Ingle; James Hobkirk; Thibaud Damy; Samantha Nabb; Andrew L Clark; John G F Cleland
Journal:  Int J Cardiol       Date:  2011-01-21       Impact factor: 4.164

Review 10.  Air travel considerations for the patients with heart failure.

Authors:  Morteza Izadi; Mohammad Javad Alemzadeh-Ansari; Davood Kazemisaleh; Maryam Moshkani-Farahani
Journal:  Iran Red Crescent Med J       Date:  2014-06-05       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.